Preethi Sundaram - Chief Strategy Officer at Catalyst Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Strategy Officer
Stock Symbol
CPRX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Preethi Sundaram - trading volume in the past year for Catalyst Pharmaceuticals, Inc.

Holdings reported by Preethi Sundaram for Catalyst Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 678K $1.52M $2.24 Feb 14, 2025 Direct Common Stock
Common Stock, par value $0.001 per share 41.1K $1.09M $26.42 Jun 11, 2025 Direct
Options to purchase common stock 709K Nov 21, 2024 Direct Common Stock

Transactions reported by Preethi Sundaram for Catalyst Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.